692 related articles for article (PubMed ID: 29922594)
1. Cancer Stem Cell Metabolism and Potential Therapeutic Targets.
Snyder V; Reed-Newman TC; Arnold L; Thomas SM; Anant S
Front Oncol; 2018; 8():203. PubMed ID: 29922594
[TBL] [Abstract][Full Text] [Related]
2. Energy metabolism in cancer stem cells.
Zhu X; Chen HH; Gao CY; Zhang XX; Jiang JX; Zhang Y; Fang J; Zhao F; Chen ZG
World J Stem Cells; 2020 Jun; 12(6):448-461. PubMed ID: 32742562
[TBL] [Abstract][Full Text] [Related]
3. An alginate-based platform for cancer stem cell research.
Qiao SP; Zhao YF; Li CF; Yin YB; Meng QY; Lin FH; Liu Y; Hou XL; Guo K; Chen XB; Tian WM
Acta Biomater; 2016 Jun; 37():83-92. PubMed ID: 27109764
[TBL] [Abstract][Full Text] [Related]
4. Targeting flavin-containing enzymes eliminates cancer stem cells (CSCs), by inhibiting mitochondrial respiration: Vitamin B2 (Riboflavin) in cancer therapy.
Ozsvari B; Bonuccelli G; Sanchez-Alvarez R; Foster R; Sotgia F; Lisanti MP
Aging (Albany NY); 2017 Dec; 9(12):2610-2628. PubMed ID: 29253841
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Targeting of Cancer Stem Cells.
Mukha A; Dubrovska A
Front Oncol; 2020; 10():537930. PubMed ID: 33415069
[TBL] [Abstract][Full Text] [Related]
6. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
[TBL] [Abstract][Full Text] [Related]
7. Cancer stem cell metabolism: target for cancer therapy.
Chae YC; Kim JH
BMB Rep; 2018 Jul; 51(7):319-326. PubMed ID: 29764565
[TBL] [Abstract][Full Text] [Related]
8. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence.
Aramini B; Masciale V; Grisendi G; Bertolini F; Maur M; Guaitoli G; Chrystel I; Morandi U; Stella F; Dominici M; Haider KH
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205721
[TBL] [Abstract][Full Text] [Related]
9. Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors.
Parte SC; Batra SK; Kakar SS
J Ovarian Res; 2018 Aug; 11(1):69. PubMed ID: 30121075
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.
De Francesco EM; Sotgia F; Lisanti MP
Biochem J; 2018 May; 475(9):1611-1634. PubMed ID: 29743249
[TBL] [Abstract][Full Text] [Related]
12. The Flick of a Switch: Conferring Survival Advantage to Breast Cancer Stem Cells Through Metabolic Plasticity.
Walsh HR; Cruickshank BM; Brown JM; Marcato P
Front Oncol; 2019; 9():753. PubMed ID: 31552162
[TBL] [Abstract][Full Text] [Related]
13. Potential Therapies Targeting Metabolic Pathways in Cancer Stem Cells.
Shen YA; Chen CC; Chen BJ; Wu YT; Juan JR; Chen LY; Teng YC; Wei YH
Cells; 2021 Jul; 10(7):. PubMed ID: 34359941
[TBL] [Abstract][Full Text] [Related]
14. Cutting the umbilical cord: Cancer stem cell-targeted therapeutics.
Banik A; Sharma R; Chauhan A; Singh S
Life Sci; 2022 Jun; 299():120502. PubMed ID: 35351466
[TBL] [Abstract][Full Text] [Related]
15. CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer.
Olivares-Urbano MA; Griñán-Lisón C; Marchal JA; Núñez MI
Cells; 2020 Jul; 9(7):. PubMed ID: 32660072
[TBL] [Abstract][Full Text] [Related]
16. Hallmarks of cancer stem cell metabolism.
Sancho P; Barneda D; Heeschen C
Br J Cancer; 2016 Jun; 114(12):1305-12. PubMed ID: 27219018
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells and tumor heterogeneity: Deciphering the role in tumor progression and metastasis.
Kapoor-Narula U; Lenka N
Cytokine; 2022 Sep; 157():155968. PubMed ID: 35872504
[TBL] [Abstract][Full Text] [Related]
18. Cancer Stem Cells: Metabolic Characterization for Targeted Cancer Therapy.
Kaur J; Bhattacharyya S
Front Oncol; 2021; 11():756888. PubMed ID: 34804950
[TBL] [Abstract][Full Text] [Related]
19. Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells.
Farace C; Oliver JA; Melguizo C; Alvarez P; Bandiera P; Rama AR; Malaguarnera G; Ortiz R; Madeddu R; Prados J
PLoS One; 2015; 10(7):e0134111. PubMed ID: 26230845
[TBL] [Abstract][Full Text] [Related]
20. Dodecyl-TPP Targets Mitochondria and Potently Eradicates Cancer Stem Cells (CSCs): Synergy With FDA-Approved Drugs and Natural Compounds (Vitamin C and Berberine).
De Francesco EM; Ózsvári B; Sotgia F; Lisanti MP
Front Oncol; 2019; 9():615. PubMed ID: 31440463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
